Home > Insider Trading > Filing (0000899243-21-015976)

Filing Details

Accession Number:: 0000899243-21-015976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-15 18:04:34
Reporting Period:: 2021-04-13

Accepted Time:: 2021-04-15 18:04:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1566469	Nanthealth Inc.	NH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189020	Patrick Soon-Shiong	C/O Nanthealth, Inc. 9920 Jefferson Blvd. Culver City CA 90232	Chief Executive Officer	Yes	Yes	Yes	No
1517764	California Capital Equity, Llc	C/O Nanthealth, Inc. 9920 Jefferson Blvd. Culver City 90230		No	No	Yes	No
1629186	Mp 13 Ventures, Llc	9920 Jefferson Blvd. Culver City CA 90232		No	No	Yes	No
1629222	Cambridge Equities, Lp	9920 Jefferson Blvd. Culver City CA 90232		No	No	Yes	No
1675760	Nantworks, Llc	9920 Jefferson Blvd. Culver City CA 90230		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-13	1,689,189	$2.96	1,689,189	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	5.50% Convertible Senior Notes due 2021	Disposition	2021-04-13	5,000,000	$5,000,000.00	411,946	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,000,000		2021-12-15	No	4	J	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	62,214,114	Indirect	See footnote
Common Stock	2,899,297	Indirect	See footnote

Footnotes

Shares are held by Cambridge Equities, LP ("Cambridge Equities"), an entity affiliated with MP 13 Ventures, LLC ("MP 13 Ventures") who is the general partner of Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the shares held by Cambridge Equities.
Shares held by NantWorks. California Capital Equity, LLC ("CalCap") directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap.
Shares held by NantOmics, LLC ("NantOmics"). NantWorks directly owns a majority of the equity interests of NantOmics. CalCap directly owns all of the equity interests of NantWorks and may be deemed to have beneficial ownership of the shares held by NantWorks. The reporting person directly owns all of the equity interests of CalCap and has voting and dispositive power over the shares held by CalCap.
The initial conversion rate of the 5.50% Convertible Senior Notes due 2021 (the "Notes") is 82.3893 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $12.14 per share), subject to adjustment pursuant to the terms of the Notes.
Portion of the Convertible Senior Note was forgiven as consideration for the purchase of shares reported in Table I.
The Notes will be convertible at the option of the reporting persons only upon the satisfaction of certain conditions prior to the close of business on the business day immediately preceding September 15, 2021. Thereafter, the Notes will be convertible at the option of the reporting persons at any time or after September 15, 2021 until the close of business on the business day immediately preceding the maturity date. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election.
The Notes are held by Cambridge Equities, an entity affiliated with MP 13 Ventures, LLC who is the general partner of Cambridge Equities and may be deemed to have beneficial ownership of the convertible notes held by Cambridge Equities. The reporting person is the sole member of MP 13 Ventures and has voting and dispositive power over the convertible notes held by Cambridge Equities.